Rivercell
Paris, France
◆ Total Raised
$25M
◆ Stage
seed
◆ Location
Paris, France
◆ Founded
2025
◆ About Rivercell
Paris-based biotechnology and AI company developing data infrastructure and AI models to predict how human cells respond to drugs and genetic changes.
◆ What sets it apart
Rivercell combines a proprietary, large-scale, time-resolved multimodal experimental-data platform with an AI world model intended to simulate cellular responses before physical testing.[2][9]
◆ Sectors
◆ Business
ModelSaaS
CustomerPharmaceutical and biotechnology companies, drug-discovery researchers, and other life-science organizations
◆ Notable
- Founded in 2025 by Yann Fleureau, founder of Cardiologs[5]
- Raised a $25 million seed round led by HV, with participation from HCVC, Alven, and Bpifrance Digital Venture[1]
- Developing an automated wet lab in Paris and an AI Virtual Cell program[1][2]
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Rivercell do?
Paris-based biotechnology and AI company developing data infrastructure and AI models to predict how human cells respond to drugs and genetic changes.
Where is Rivercell based?
Rivercell is based in Paris, France, founded in 2025.
How much has Rivercell raised?
Rivercell has raised $25M in tracked funding and is currently at the seed stage.
Who has invested in Rivercell?
Investors in Rivercell include HV, HCVC, Alven and Bpifrance Digital Venture.